TATA Health International Holdings Ltd. (HK:1255) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
TATA Health International Holdings Ltd. faces continued trading suspension on the Hong Kong Stock Exchange due to delays in publishing financial results for 2023 and the first half of 2024, and must satisfy resumption guidance by October 1, 2025, to avoid delisting. The company, primarily engaged in footwear alongside financial services, healthcare, and online medical services, is operating most of these sectors at minimal levels and is working on an action plan to resume trading.
For further insights into HK:1255 stock, check out TipRanks’ Stock Analysis page.